We are 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one CAS:120004-79-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one
CAS.NO: 120004-79-7
Synonyms:
7-(4-chlorobutoxy)-3,4-dihydro-1H-quinolin-2-one
Molecular Formula: C13H16ClNO2
Molecular Weight:253.72500
Physical and Chemical Properties:
Density: 1.187 g/cm3
Boiling point: 448.925ºC at 760 mmHg
Melting point: /
Flash point: 225.302ºC
Refractive index: 1.543
Specification:
Appearance:White to off-white crystalline powder
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Aripiprazole CAS:129722-12-9
Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.2-[3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.bromuro de sodio CAS:7647-15-6 It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.5- (2-fluorofenil) -1H-pirrol-3-carboxaldehído CAS:881674-56-2 It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.
Product Name | |
---|---|
methyl 2-[(4-methylphenyl)sulfonylamino]acetate | View Details |
1-dodecyl-3-methylimidazolium hexafluorophosphate | View Details |
Argipressin Acetate | View Details |